Ajax-Loading

Eli Lilly and Company - Total Long Term Assets

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Long-Term-Assets" stands at 52.86 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Total Long Term Assets" stands at 52.86 Billion USD. This represents an increase of 3.52 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.62 percent compared to the value the year prior.
The 1 year change in percent is 19.62.
The 3 year change in percent is 77.27.
The 5 year change in percent is 90.80.
The 10 year change in percent is 122.70.

The Serie's long term average value is 27.50 Billion United States Dollars. It's latest available value, on 09/30/2025, is 92.23 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +227.10%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Total Long Term Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Total Long Term Assets486,508,953,600.00
LogoAbbVie Inc - Total Long Term Assets399,570,305,024.00
LogoRoche Holding AG - Total Long Term Assets317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Assets280,205,508,085.11
LogoNovartis AG - Total Long Term Assets255,096,620,580.91